Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Accesswire May 3, 2021

The StockTalk Cannabis Report: Apr 30, 2021

Dave Jackson April 30, 2021

Next Super Stocks on The Move: Tetra Bio-Pharma, ESE Entertainment, Red Light Holland, and Skylight Health. Innovation Leaders in E-Sports, Healthcare, Psychedelics, and Pharma Targeting Billion Dollar Markets.

GlobeNewswire April 29, 2021

Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority

Accesswire April 28, 2021

Tetra Bio-Pharma (TSX:TBP) provides an update on its U.S. REBORN1 clinical trial

John Ballem  April 23, 2021

Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial

Accesswire April 23, 2021

Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis

Accesswire April 15, 2021

Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada

Accesswire April 14, 2021

FDA Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 Clinical Development in COVID-19 Patients

Accesswire April 5, 2021

Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada

Accesswire April 1, 2021

NEXT SUPER STOCKS Addressing Multi-Billion Dollar Healthcare Markets: Tetra Bio-Pharma, Relay Medical, Skylight Health, Reliq HealthTech

GlobeNewswire March 31, 2021

Health Canada Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome

Accesswire March 30, 2021

Tetra Bio-Pharma Initiates Additional Studies on Leading Drug Candidate ARDS-003

Accesswire March 26, 2021

Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada

Accesswire March 18, 2021

Tetra Bio-Pharma Provides Status of Its New Drug Submission Application in Canada

Accesswire March 15, 2021

Correction To Tetra Bio-Pharma News Release Dated February 25th

Accesswire March 8, 2021

Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Accesswire March 3, 2021

Tetra Bio-Pharma Announces Closing of Bought Deal Offering

Canada NewsWire March 2, 2021

Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios

Accesswire February 25, 2021

Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of Units

Canada NewsWire February 22, 2021